Rafael Holdings Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 1.6, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Rafael Holdings Inc in Apr 30 2026 quarter, has decreased to 228 days, compared to 263 days, in the Oct 31 2025 quarter.

If we take a look into Healthcare sector 515 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3364, from overall ranking in the first quarter 2025 at 3495.

What is Receivable Turnover Ratio?
What is Rafael Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RFL Receivables Turnover Ratio	(Apr 30 2026) III. Quarter	(Oct 31 2025) I. Quarter	(Jul 31 2025) IV. Quarter	(Apr 30 2025) III. Quarter	(Jan 31 2025) II. Quarter
Y / Y Receivable Change	-28.99 %	47.5 %	105.47 %	330.28 %	-6.55 %
Y / Y Revenue Change	132.47 %	87.5 %	112.12 %	7.74 %	13.24 %
Receivable Turnover Ratio (TTM)	1.6	1.39	1.28	1.11	2.28
RFL's Total Ranking	# 3364	# 3495	# 3273	# 3478	# 3344
Accounts Receivable average collection period days	229	262	285	330	160
Seq. Receivable Change	-0.34 %	-28.57 %	-77.47 %	342.75 %	107 %
Seq. Revenue Change	-25.42 %	-31.43 %	-3.31 %	370.13 %	-39.84 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 169
Healthcare Sector	# 516
Overall Market	# 3364

Receivable Turnover Ratio Statistics
High	Average	Low
18.63	5.67	0.22
(Jan 31 2021)		(Jan 31 2024)

RFL Company Profile • Back to RFL Efficiency Comparisons • Compare RFL Receivables Turnover Ratio to its Competitors

Financial Statements
Rafael Holdings Inc's Accounts Receivable	$ 0 Millions	Visit RFL's Balance sheet
Rafael Holdings Inc's Sales TTM	$ 1 Millions	Visit RFL's Income Statement
Sources of RFL's Revenues		Visit RFL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RFL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RFL's Growth Rates	RFL's Roa	RFL's Inventory Turnover Ratio	RFL's Dividend Comparisons
RFL's Profitability Ratios	RFL's Roi	RFL's Asset Turnover Ratio	RFL's Dividend Growth
RFL's Valuation Ratios	RFL's Roe	RFL's Financial Strength Ratios	RFL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Apr 30 2026	Receivable at quarter ending Apr 30 2026
Immucell Corporation	10.51	$ 29.035 Millions	$ 2.762 Millions
Kestra Medical Technologies Ltd	10.51	$ 93.819 Millions	$ 8.925 Millions
Lifeloc Technologies Inc	10.41	$ 9.044 Millions	$ 0.869 Millions
Monte Rosa Therapeutics Inc	10.39	$ 42.953 Millions	$ 4.136 Millions
International Stem Cell Corporation	10.23	$ 9.286 Millions	$ 0.908 Millions
Pavmed Inc	10.19	$ 0.107 Millions	$ 0.011 Millions
Viemed Healthcare Inc	10.16	$ 286.565 Millions	$ 28.217 Millions
Addus Homecare Corp	10.14	$ 1,447.070 Millions	$ 142.667 Millions
Utah Medical Products Inc	10.13	$ 36.745 Millions	$ 3.629 Millions
Petvivo Holdings Inc	10.10	$ 0.821 Millions	$ 0.081 Millions
Irhythm Holdings Inc	10.00	$ 787.387 Millions	$ 78.720 Millions
C4 Therapeutics Inc	9.97	$ 34.861 Millions	$ 3.496 Millions
Biodesix Inc	9.94	$ 96.096 Millions	$ 9.665 Millions
Radnet Inc	9.87	$ 2,144.442 Millions	$ 217.223 Millions
Lensar Inc	9.87	$ 57.704 Millions	$ 5.847 Millions
X4 Pharmaceuticals Inc	9.69	$ 9.014 Millions	$ 0.931 Millions
Septerna Inc	9.64	$ 72.255 Millions	$ 7.499 Millions
Encompass Health Corporation	9.63	$ 6,066.400 Millions	$ 629.625 Millions
Biolife Solutions Inc	9.51	$ 99.673 Millions	$ 10.478 Millions
Biofrontera Inc	9.49	$ 42.983 Millions	$ 4.530 Millions
United Therapeutics Corporation	9.47	$ 3,169.800 Millions	$ 334.800 Millions
Tandem Diabetes Care Inc	9.34	$ 1,023.420 Millions	$ 109.550 Millions
Sunshine Biopharma Inc	9.33	$ 35.493 Millions	$ 3.804 Millions
The Oncology Institute Inc	9.30	$ 545.764 Millions	$ 58.671 Millions
The Pennant Group Inc	9.28	$ 1,023.227 Millions	$ 110.305 Millions
Enanta Pharmaceuticals Inc	9.26	$ 69.213 Millions	$ 7.477 Millions
Volitionrx Limited	9.23	$ 2.466 Millions	$ 0.267 Millions
Lucid Diagnostics Inc	9.11	$ 5.134 Millions	$ 0.564 Millions
Soleno Therapeutics Inc	9.09	$ 285.008 Millions	$ 31.369 Millions
Dariohealth Corp	9.03	$ 20.983 Millions	$ 2.324 Millions

Date modified: 2026-09-08T15:11:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.